- Conditions
- B-Cell Prolymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +51 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
- Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Clinical trial condition
Refractory Plasma Cell Myeloma
Explore clinical trials studying Refractory Plasma Cell Myeloma. Study availability and eligibility vary by location and protocol.
55 public trials
4 recruiting studies
Refractory Plasma Cell Myeloma trial results
NCT01794039
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01936090
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Plasma Cell Myeloma, +16 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01689987
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT01085214
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
- Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
NCT01533194
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT00066638
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DS Stage II Plasma Cell Myeloma, +15 more
- Locations
-
- Montefiore Medical Center - Moses Campus The Bronx, New York, United States
NCT00082784
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, +33 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina Charleston, South Carolina, United States
NCT01330173
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Plasma Cell Myeloma, +16 more
- Locations
-
- University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States
Active, Not Recruiting
Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma
NCT04850599
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States